Guardian Pharmacy Services (NYSE:GRDN) Stock Bumped Down to "Hold" by Wall Street Zen

Key Points

• Wall Street Zen downgraded Guardian Pharmacy Services from “Buy” to “Hold,” though the broader analyst consensus remains “Moderate Buy,” with nine Buy ratings and one Hold rating.
• Other analysts raised their price targets to between $49 and $52, while the consensus target stands at $45.57 compared with the stock’s recent price of $39.42.
• Guardian exceeded quarterly expectations, reporting $0.29 in EPS versus $0.26 expected and revenue of $351.77 million versus $340.45 million forecast.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) was downgraded by equities researchers at Wall Street Zen from a "buy" rating to a "hold" rating in a note issued to investors on Sunday, Wall Street Zen reports.

Other research analysts have also recently issued reports about the stock. Truist Financial increased their price target on shares of Guardian Pharmacy Services from $47.00 to $51.00 and gave the company a "buy" rating in a research report on Monday, September 21st. KeyCorp assumed coverage on shares of Guardian Pharmacy Services in a report on Tuesday, September 22nd. They issued an "overweight" rating and a $52.00 price objective for the company. Oppenheimer upped their price objective on shares of Guardian Pharmacy Services from $43.00 to $49.00 and gave the company an "outperform" rating in a research note on Friday, August 7th. Finally, Weiss Ratings lowered shares of Guardian Pharmacy Services from a "buy (b)" rating to a "buy (b-)" rating in a report on Friday. Nine analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $45.57.

Guardian Pharmacy Services Stock Down 0.4%

NYSE GRDN opened at $39.42 on Friday. The stock's 50-day simple moving average is $40.92 and its two-hundred day simple moving average is $39.96. Guardian Pharmacy Services has a twelve month low of $26.34 and a twelve month high of $48.33. The company has a market capitalization of $1.96 billion, a price-to-earnings ratio of 38.28, a PEG ratio of 2.06 and a beta of 0.03.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last posted its quarterly earnings data on Thursday, August 6th. The company reported $0.29 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.26 by $0.03. The firm had revenue of $351.77 million during the quarter, compared to analysts' expectations of $340.45 million. Guardian Pharmacy Services had a return on equity of 29.97% and a net margin of 4.50%. On average, equities analysts expect that Guardian Pharmacy Services will post 1.18 earnings per share for the current fiscal year.

Institutional Trading of Guardian Pharmacy Services

Institutional investors and hedge funds have recently bought and sold shares of the stock. Jennison Associates LLC lifted its position in Guardian Pharmacy Services by 609.5% during the 1st quarter. Jennison Associates LLC now owns 822,784 shares of the company's stock valued at $30,986,000 after acquiring an additional 706,823 shares during the period. Braun Stacey Associates Inc. bought a new stake in Guardian Pharmacy Services during the second quarter worth about $14,234,000. Ranger Investment Management L.P. bought a new stake in Guardian Pharmacy Services during the second quarter worth about $7,263,000. Dimensional Fund Advisors LP boosted its stake in Guardian Pharmacy Services by 200.0% during the first quarter. Dimensional Fund Advisors LP now owns 208,594 shares of the company's stock worth $7,855,000 after acquiring an additional 139,070 shares in the last quarter. Finally, Sei Investments Co. grew its holdings in Guardian Pharmacy Services by 40.5% in the first quarter. Sei Investments Co. now owns 358,181 shares of the company's stock worth $13,489,000 after purchasing an additional 103,177 shares during the period.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc is a provider of pharmacy services focused primarily on residents of long-term care and other institutional healthcare settings. Through its network of pharmacies, the company supplies prescription medications and related pharmacy support to assisted living communities, skilled nursing facilities, behavioral health organizations, and other care providers.

The company's services include medication dispensing and packaging, prescription delivery, medication management, clinical pharmacy support, and technology-enabled tools designed to help caregivers and healthcare professionals manage residents' medication regimens.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.